Abstract—Hypertension is a well-known risk factor for coronary artery disease and carotid and lower extremity occlusive disease. Surgically induced hypertension in hypercholesterolemic animals results in increased aortic wall motion and increased plaque formation. We tested the hypothesis that reduction in aortic wall motion, despite continued hypertension, could reduce plaque formation. New Zealand White rabbits (n526) underwent thoracic aortic banding to induce hypertension and were fed an atherogenic diet for 3 weeks. In 13 rabbits, a segment of aorta proximal to an aortic band was externally wrapped to reduce wall motion. All animals were fed an atherogenic diet for 3 weeks. Four groups were studied: 1, coarctation control (no wrap, n57...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
<div><p>Objective</p><p>To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) o...
To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of atheroscle...
Purpose: Hypertension is a known clinical risk factor for atherosclerosis. In experimental atheroscl...
There has been increased attention focused on atherosclerosis, with a rise in the number of investig...
Abstract Background Atherosclerosis is a diffuse and highly variable disease of arteries that alters...
Increased plaque vascularization is causatively associated with the progression of unstable atherosc...
Increased plaque vascularization is causatively associated with the progression of unstable atherosc...
AbstractPurpose. Abdominal aortic aneurysm (AAA) usually is associated with atherosclerosis. We atte...
ObjectivesThis study was designed to investigate the association between hypertension and aortic val...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
<div><p>Objective</p><p>To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) o...
To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of atheroscle...
Purpose: Hypertension is a known clinical risk factor for atherosclerosis. In experimental atheroscl...
There has been increased attention focused on atherosclerosis, with a rise in the number of investig...
Abstract Background Atherosclerosis is a diffuse and highly variable disease of arteries that alters...
Increased plaque vascularization is causatively associated with the progression of unstable atherosc...
Increased plaque vascularization is causatively associated with the progression of unstable atherosc...
AbstractPurpose. Abdominal aortic aneurysm (AAA) usually is associated with atherosclerosis. We atte...
ObjectivesThis study was designed to investigate the association between hypertension and aortic val...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of ...
<div><p>Objective</p><p>To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) o...
To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of atheroscle...